FDA writes a new question for the committee, after advisers rejected broad booster use.
Notably, this question is for *emergency authorization* of a third dose of Pfizer's vaccine, NOT approval as Pfizer had applied for. pic.twitter.com/bkdo3oMod2
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.